Rheumatoid Arthritis Clinical Trials in Chicago

Showing 2321-2340 of 3,348 trials

rTMS: A Treatment to Restore Function After Severe TBI

NCT02366754

The purpose of this study is to address the need for targeted treatments that induce functional and structural changes in the brain, ultimately improving neurobehavioral functioning, the investigators propose examining the therapeutic effectiveness of repetitive Transcranial Magnetic Stimulation (rTMS). The objective is to improve functional recovery for persons remaining in vegetative (VS) and minimally conscious (MCS) states 3 to 24 months after severe TBI. The approach is to determine the neurobehavioral effect of rTMS, the relationship between neurobehavioral changes and net neural effects, and to identify and define the neural mechanisms related to neurobehavioral improvements by providing 30 active or placebo rTMS sessions.

Traumatic Brain Injury

Edward Hines Jr. VA Hospital58 participantsStarted Feb 2016

Chicago, Illinois, United States • Hines, Illinois, United States

COMPLETED2.2 miles

Markers of Inflammation in Hematopoietic Stem Cell Transplant

NCT00579397

Objectives: 1. To show feasibility and reproducibility of performing a multiplex ligation-dependent amplification procedure (RT-MLPA) 2. To describe the profile of changes in inflammatory gene products, using RT-MLPA, in pediatric patients receiving stem cell transplant 3. To determine if changes in a specific inflammatory product, or a combination of inflammatory products, can predict grade 2-4 acute graft-versus-host disease

Acute Graft Versus Host Disease

Ann & Robert H Lurie Children's Hospital of Chicago30 participantsStarted Apr 2007

Chicago, Illinois, United States

rTMS: A Treatment to Restore Function After Severe TBI

Markers of Inflammation in Hematopoietic Stem Cell Transplant

Rheumatoid Arthritis Trials in Other Cities

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

Anesthesia Information System vs Paper Anesthesia Records for Care Congruency

Use of Cyclobenzaprine After Vaginal Surgery

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

A Study in Moderate to Severe Rheumatoid Arthritis Participants

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

TransForm™ Occlusion Balloon Catheter Registry

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

Soft Contacts Observation of Risk and Education (SCORE)

SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma

A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Other Conditions in Chicago